Related Experiment Video
Updated: Jun 3, 2026
06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
Effect of cigarette smoking on platelet aggregation.
Burak Pamukcu1, Huseyin Oflaz, Imran Onur
1Istanbul University, Istanbul Faculty of Medicine, Department of Cardiology, Istanbul, Turkey. bpamukcu@gmail.com
Summary
Cigarette smoking significantly increases platelet aggregation in patients with ischemic coronary heart disease (CHD), even with aspirin therapy. Quitting smoking is crucial for these patients to improve cardiovascular health.
Area of Science:
- Cardiovascular Medicine
- Hematology
- Clinical Research
Background:
- Cigarette smoking is a known risk factor for atherothrombotic cardiovascular events.
- Its impact on platelet function in patients with ischemic coronary heart disease (CHD) requires further investigation.
Purpose of the Study:
- To investigate the effect of cigarette smoking on platelet function in patients with ischemic CHD undergoing aspirin therapy.
- To assess whether smoking influences aspirin responsiveness in this patient group.
Main Methods:
- Twenty smokers and 20 non-smokers with stable ischemic CHD on aspirin therapy were enrolled.
- Platelet function was assessed using the Platelet Function Analyzer (PFA)-100 before and after smoking the first cigarette.
- Aspirin non-responsiveness was defined as a closure time (CT) < 186 seconds.
Main Results:
- Cigarette smoking significantly increased platelet activity (P = .004).
- Smoking led to shorter CTs in all patients, converting more participants into aspirin non-responders (P = .004).
- No significant demographic, hematological, or biochemical differences were found between aspirin responders and non-responders.
Conclusions:
- Cigarette smoking enhances platelet aggregation in ischemic CHD patients, potentially in an aspirin non-responsive manner.
- These findings underscore the critical importance of smoking cessation for patients with CHD to mitigate cardiovascular risk.
Related Concept Videos
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:17Intracellular Signaling Affects Focal Adhesions
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
01:18Structure and Function of Platelets
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...